Skip to content
Screener

Elanco Animal Health Inc. ELAN Pet Health — Revenue

Other product segments

Cattle
$313M+16.8%
Poultry
$223M+3.7%
Swine
$97M-3.0%
Contract Manufacturing
$17M+13.3%

Similar metrics at other companies

Willis Towers Watson logo
WTWHealth Wealth And Career — Revenue
$1.29B+7.8%
Marsh logo
MRSHHealth — Revenue
$611M+2.9%
Nakamoto, Inc. logo
NAKAHealth Care — Revenue
$479K-17.4%
Myriad Genetics logo
MYGNMental Health — Revenue
$38.3M+23.5%
Myriad Genetics logo
MYGNPrenatal Health — Revenue
$41.9M-15.0%
Phibro Animal Health logo
PAHCAnimal Health — Revenue
$291.23M+12.7%

Other financials

Income statement

See full
Revenue$1.4B+10.2%
Gross profit$798.0M+11.9%
Net income$54.0M+391%
EPS (diluted)$0.11+450%

Balance sheet

See full
Cash & equivalents$530.0M-1.7%
Total debt$4.2B-6.2%
Total equity$6.6B-2.8%
Total assets$13.6B-1.3%

Cash flow

See full
Operating cash flow$277.0M+16.9%
CapEx$33.0M-42.1%
Free cash flow$244.0M+35.6%

Valuation

See full
Market cap$13.1B+89.0%
Enterprise value$16.81B+54.0%
P/S2.6×+1.1×

Profitability

See full
Gross margin55.4%+0.6pp
Net margin-4%-13.8pp
FCF margin7.5%-0.5pp

Returns & leverage

See full
Return on equity-3%-9.9pp
Debt / equity0.6×0.0×
Current ratio2.1×-0.5×

Where this comes from

Reported directly by Elanco Animal Health Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Elanco Animal Health Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:06 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001739104-26-000043
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue$1,368$1,241$2,739$2,434
Cost of sales5705281,1561,037
Gross profit7987131,5831,397
Research and development9292189186
Marketing, selling and administrative449400830741
Amortization of intangible assets139136277264
Asset impairment, restructuring and other special charges912510
Interest expense, net of capitalized interest594811688

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Elanco Animal Health Inc.'s pet health — revenue?
Elanco Animal Health Inc. (ELAN) reported pet health — revenue of $718M in Q2 2026.
How has Elanco Animal Health Inc.'s pet health — revenue changed year-over-year?
Elanco Animal Health Inc.'s pet health — revenue increased by 11.7% year-over-year, from $643M to $718M.
What is the long-term trend for Elanco Animal Health Inc.'s pet health — revenue?
Over 4 years (2021 to 2025), Elanco Animal Health Inc.'s pet health — revenue has grown at a -0.5% compound annual growth rate (CAGR), from $2.35B to $2.3B.
What does pet health — revenue mean?
This metric represents the total gross sales generated from the company's portfolio of products dedicated to companion animals, including dogs, cats, and other household pets. It reflects the market demand for therapeutic, preventative, and nutritional solutions within the consumer-facing animal health sector. Tracking this revenue stream provides insight into the company's ability to capture value from the growing pet care market and the performance of its specific companion animal brand portfolio.

Ask your AI about Elanco Animal Health Inc.'s pet health — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude